Sheehan's syndrome pathophysiology

Jump to navigation Jump to search

Sheehan's syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sheehan's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sheehan's syndrome pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sheehan's syndrome pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sheehan's syndrome pathophysiology

CDC on Sheehan's syndrome pathophysiology

Sheehan's syndrome pathophysiology in the news

Blogs on Sheehan's syndrome pathophysiology

Directions to Hospitals Treating Sheehan's syndrome

Risk calculators and risk factors for Sheehan's syndrome pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Iqra Qamar M.D.[2]

Overview

Pathophysiology



 
DIC
 
 
Severe PPH
 
 
Glandular hypertrophy and hyperplasia
 
 
Small sella size
 
 
Autoimmunity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypotension/Shock
 
 
Pituitary enlargement
 
 
Pituitary compression
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blood supply compression
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ischemic Necrosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypopituitarism
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amenorrhea
 
 
Agalactorrhea
 
 
 
Secondary adrenal insufficiency
 
 
Hypothyroidism
 


‡:Amniotic fluid embolism, HELLP Syndrome.
†:>500ml after vaginal delivery, 1000ml after C-section

Pathogenesis

  • Pituitary gland is amongst the most vascularized tissues in the body that normally weighs about 0.5g but gets doubled in size during pregnancy.[5] Pituitary gland enlargement due to hypertrophy and hyperplasia of lactotrophic cells in anterior pituitary resulting in superior hypophyseal artery compression complicated by decreased portal pressure and vasospasm during delivery play an important role in the pathogenesis of Sheehan syndrome.[6]
  • Apart from pituitary gland enlargement during and before parturition, vasospasm, generalized Schwartzman phenomenon ,thrombosis and compression of the hypophyseal arteries, autoimmunity, DIC and smaller size of sella are thought to play a contributing role in pathogenesis of sheehan Syndrome.[1][7][3] It is thought that tissue necrosis results in release of sequestered antigens, precipitating autoimmunity of the pituitary gland and hypopituitarism in Sheehan's syndrome.[8] Type 1 diabetes, pre-existinfg vascular diseases and any pituitary masses are associated with increased risk of developing Sheehan syndrome in pregnancy. [9]
  • Anterior pituitary does not have a direct blood supply and is supplied by hypophyseal portal system. The hypophyseal portal system is a fenestrated set of capillaries and allows rapid exchange of hormones between hypothalamus and anterior pituitary. Occlusions and other issues in the blood vessels of the hypophyseal portal system can also cause complications in the exchange of hormones between the hypothalamus and the pituitary gland leading to hypopituitarism.
  • Posterior pituitary has its own blood supply via inferior hypophyseal artery and is less affected compared to anterior pituitary. If affected, can result in neurohypophseal dysfunction and ischemic necrosis of thirst center leading to increased osmotic threshold for thirst onset.[10]
  • Severe PPH (loss of >500ml of blood during the first 24hr) leading to hypotension and ischemic necrosis of pituitary gland is the most common cause of Sheehan syndrome.[1]
  • Sheehan's syndrome results in mild to severe pituitary dysfunction resulting in partial or panhypopituitarism such as GH, Thyroid hormone, glucocorticoid, gonadotropins(LH, FSH) and prolactin hormone deficiencies that manifests as a wide spectrum of presentation.[4] Usually, GH is the earliest one to be lost.[1]

Genetics

There is no genetic association found to be associated with Sheehan's syndrome.

Associated Conditions

Sheehan's syndrome is associated with:

  • Pregnancy
  • PPH
  • Hypotension

Gross Pathology

  • On gross pathology, pituitary gland follows sequential changes of enlarged pituitary gland to a small shrunken/atrophic gland later on replaced by remnants of pituitary or CSF fluid.

Microscopic Pathology

On microscopy, the following findings may be observed:

  • Ischemic necrosis leading to scarring of neurohypophysis
  • Scarring of para-ventricular and supra-optic nuclei

References

  1. 1.0 1.1 1.2 1.3 1.4 Keleştimur F (2003). "Sheehan's syndrome". Pituitary. 6 (4): 181–8. PMID 15237929.
  2. Apitz, Kurt (September 1, 1935). "A Study of the Generalized Shwartzman Phenomenon". The Journal of Immunology. 29 (3): 255–266.
  3. 3.0 3.1 McKay, Donald G.; Merrill, Samuel J.; Weiner, Albert E.; Hertig, Arthur T.; Reid, Duncan E. (1953). "The pathologic anatomy of eclampsia, bilateral renal cortical necrosis, pituitary necrosis, and other acute fatal complications of pregnancy, and its possible relationship to the generalized Shwartzman phenomenon". American Journal of Obstetrics and Gynecology. 66 (3): 507–539. doi:10.1016/0002-9378(53)90068-4. ISSN 0002-9378.
  4. 4.0 4.1 Vance ML (1994). "Hypopituitarism". N. Engl. J. Med. 330 (23): 1651–62. doi:10.1056/NEJM199406093302306. PMID 8043090.
  5. Rolih CA, Ober KP (1993). "Pituitary apoplexy". Endocrinol. Metab. Clin. North Am. 22 (2): 291–302. PMID 8325288.
  6. Scheithauer BW, Sano T, Kovacs KT, Young WF, Ryan N, Randall RV (1990). "The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases". Mayo Clin. Proc. 65 (4): 461–74. PMID 2159093.
  7. Apitz, Kurt (September 1, 1935). "A Study of the Generalized Shwartzman Phenomenon". The Journal of Immunology. 29 (3): 255–266.
  8. Goswami R, Kochupillai N, Crock PA, Jaleel A, Gupta N (2002). "Pituitary autoimmunity in patients with Sheehan's syndrome". J. Clin. Endocrinol. Metab. 87 (9): 4137–41. doi:10.1210/jc.2001-020242. PMID 12213861.
  9. Abourawi, F (2006). "Diabetes Mellitus and Pregnancy". Libyan Journal of Medicine. 1 (1): 28–41. doi:10.4176/060617. ISSN 1993-2820.
  10. Atmaca H, Tanriverdi F, Gokce C, Unluhizarci K, Kelestimur F (2007). "Posterior pituitary function in Sheehan's syndrome". Eur. J. Endocrinol. 156 (5): 563–7. doi:10.1530/EJE-06-0727. PMID 17468192.

Template:WH Template:WS